TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/17/2026 01:02 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $27.50. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $4,195,705 vs put $0. RSI 26.2.
- Symbol
- ACAD
- Price
- $27.50
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-17 13:02:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume: 100% call volume, $4,195,705
Pure directional positioning suggests near-term bullish expectations.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 12.35 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 7.26 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment.
- The company reports strong quarterly earnings, beating analyst expectations.
- ACADIA Pharmaceuticals faces increased competition in the pharmaceutical industry.
These headlines may impact the stock's price action and sentiment. The FDA approval and strong earnings report could be positive catalysts, while increased competition could be a negative factor.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $1,138,643,000
- Trailing EPS: $2.23
- Trailing P/E: 12.35
- Price-to-Book: 7.26
- Debt-to-Equity: 0.33
- Return on Equity (ROE): 29.12%
The company's revenue and EPS are strong, with a relatively low P/E ratio. However, the high price-to-book ratio and debt-to-equity ratio may be concerns.
Current Market Position:
Current price: $27.49
Recent price action: The stock has been trading in a range with a slight upward trend.
Key support and resistance levels:
| Level | Price |
|---|---|
| Support | $26.64 |
| Resistance | $30.96 |
Technical Analysis:
SMA trends:
| SMA | Price |
|---|---|
| 5-day SMA | $27.43 |
| 20-day SMA | $28.50 |
| 50-day SMA | $27.59 |
RSI (14): 26.17 (oversold)
MACD: -0.19 (bearish)
Bollinger Bands: Middle band at $28.50, upper band at $30.47, lower band at $26.52
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume: 100% call volume, $4,195,705
Pure directional positioning suggests near-term bullish expectations.
Key Price Levels:
Support: $26.64, $27.00
Resistance: $30.96, $29.00
25-Day Price Forecast:
ACAD is projected for $27.50 to $30.00
Based on current technical trends, momentum, and indicators.
Defined Risk Strategy Recommendations:
Based on the price forecast:
- Buy Bull Call Spread: ACAD 261016C00027000 and sell ACAD 261016C00030000
- Sell Bear Put Spread: ACAD 261016P00024000 and buy ACAD 261016P00021000
- Iron Condor: ACAD 261016C00026000, ACAD 261016C00028000, ACAD 261016P00026000, and ACAD 261016P00024000
These strategies align with the projected price range and provide defined risk.
Risk Factors:
Technical warning signs: RSI oversold, bearish MACD
Sentiment divergences: None
Volatility and ATR considerations: High volatility could impact trades
Summary & Conviction Level:
Overall bias: Bullish
Conviction level: Medium
One-line trade idea: Buy ACAD with a bullish bias.
View ACAD Options Chain